Floatz logo

Lomustine

AIDS-related Small Noncleaved Cell Lymphoma

Federal Research Institute of Pediatric Hematology, Oncology and ImmunologySmall moleculePhase 4 / ApprovedActive
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

73 Active assets in the AIDS-related Small Noncleaved Cell Lymphoma cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 4BBB
VINCRISTINE SULFATE
AIDS Malignancy Consortium
Phase 2BBB
VINDESINE
PETHEMA Foundation
Phase 4BBB
Cyclophosphamide
AIDS Malignancy Consortium
Phase 4BBB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 2BBB

View all 50 →

Same molecule, other indications

Lomustine is also rated in:

central nervous system neoplasmDormant
BB
Indicative ·
68 / 100
View asset →
glioblastomaDormant
BB
Indicative ·
67 / 100
View asset →
diffuse large B-cell lymphomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →